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Abstract: The fl owers of the Chiliotrichum diffusum (G. Forst.) Kuntze, Asteraceae, 
have long been used in traditional medicine and rituals. In this study, the anti-
infl ammatory and antinociceptive activities of a decoction of the fl owers were evaluated 
and a phytochemical analysis was performed by HPLC-DAD. In order to evaluate 
the antinociceptive activity, the acetic acid-induced abdominal writhing and hot plate 
tests were used. The anti-infl ammatory activity was evaluated using carrageenan-
induced rat paw oedema. The decoction induced a signifi cant anti-infl ammatory effect 
(inhibition of 56.0% at 3 h) and produced signifi cant inhibition on nociception in the 
acetic acid test (ED50 35 mg/kg i.p.; ED50 709 mg/kg p.o.). In the hot plate test, the 
antinociceptive activity of the extract employed at 500 mg/kg i.p. was signifi cantly 
suppressed by pretreatment with naloxone (5 mg/kg). HPLC analysis showed the 
presence of chlorogenic acid, caffeic acid, hyperoside, isoquercitrin, quercitrin, 
afzelin, quercetin, apigenin and kaempferol. The decoction of C. diffusum proved to 
have antinociceptive and anti-infl ammatory effects that may be related to the presence 
of the fl avones, fl avonols and phenolic acids identifi ed. The opiod system seems to be 
involved in the mechanism of antinociception of the extract. 
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Introduction
 Chiliotrichum diffusum (G. Forst.) Kuntze, 
Asteraceae, is known with the common name of  “mata 
negra” or “kóor” (Shelkman or Ona´s language) and it is 
widely distributed in Southern Argentina. It is a medium, 
branched bush, 50-150 cm high, growing in the Andean 
region. It is commonly used as food for ovines (Ballaré 
et al., 2001). This autochthonous specie has had a great 
impact in the biodiversity patterns in the Andean region, 
having an appreciable degree of sociability with other 
species. For these reasons, this species would represent a 
promissory natural resource for rational exploitation. 
 The aerial part of this plant has been used in 
tatoos  (“lóiste” in Shelkman or Ona language) in rituals 
carried out by original people. Besides, the fl owers 
have been traditionally used to “clarify the sight” (Vera, 
1991). Although this term is not certainly clear, however 
it is possible that it is related with an anti-infl ammatory 
activity, since infl ammation of the conjunctiva is one of 
the commonest ocular disorders. Besides, since ancient 
times, a lot of medicinal plants have been used in ocular 
ailments (de Brizuela, 2003; Abdul et al., 2010). In this 
sense, Klauss & Adala (1994) reported that the words 
employed by African healers to describe eye diseases were 
mostly related with the infl ammatory process. 
 Other species belonging to the Asteraceae 
family have proved to possess anti-infl ammatory and 
antinociceptive activities and some of them are also used 
for eye diseases (Tavares Carvalho, 2004; Dos Santos et 
al., 2010; Srivastava et al., 2010; Shah et al., 2011). It has 
been demonstrated that these species possess phenolic 
acids, such as anthocyanins, fl avonols, fl avones with high 
antioxidant activity (Alcalde, et al., 2008), therefore, it is 
likely that C. diffusum also possesses such activities. 
 Based on these considerations and taking into 
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account that no pharmacological studies with this plant 
have been performed so far, the aim of this work was to 
evaluate the possible anti-inflammatory and antinociceptive 
activities of the aqueous extract of C. diffusum, using 
classical experimental models of inflammation and pain. A 
phytochemical analysis was also performed.
Materials and Methods
Plant material
 Flowers of Chiliotrichum diffusum (G. Forst.) 
Kuntze, Asteraceae, were collected in summer, in 28 
de Noviembre town (Santa Cruz province, Argentina). 
A voucher specimen was kept in the Herbario Regional 
Patagónico, Facultad de Ciencias Naturales, Universidad 
Nacional de la Patagonia San Juan Bosco (number HRP 
5305).
Preparation of the aqueous extract 
 The flowers were dried at room temperature 
and ground to powder mechanically. The decoction was 
prepared according to the Farmacopea Nacional Argentina 
(1978) by pouring 100 mL of cold water onto the 5 g of 
the ground flowers heating to boiling point and allowing to 
simmer for 20 min at 100 ºC. The temperature was kept in 
boiling water bath. The extract was then filtered, to separate 
the plant residue and the filtered was concentrated using a 
rotary vaccum evaporator followed by lyophilization. The 
yield of this extract was 36% (w/w). Before use, the dried 
extract was dissolved in saline or water for systemic or 
oral administration, respectively. 
Phytochemical studies by HPLC-DAD
 The HPLC analysis was performed in a Waters 
HPLC system consisting of a Waters 1525 Binnary HPLC 
Pump and Rheodyne (20 μL) injector. The instrument was 
equipped with a Waters 2996 Photodiodo Array Detector. 
A Waters symmetric 300 (5 μ) reverse-phase C-18 column 
(250 x 4.6 mm) was used. As mobile phase, acetonitrile 
(solvent A) and water-acetic acid (40:1, solvent B) were 
used. The elution gradient consisted of 15% solvent A and 
85% solvent B, for 15 min, it was followed by a linear 
gradient to 65% solvent B for 30 min and then a sharp 
transition to 0% solvent B in 2 min. The chromatographic 
separation was performed at room temperature at a flow 
rate 1.0 mL.min-1. The elution was monitored at 360 nm. 
The identification of each compound was achieved by 
comparing the retention times and UV spectra with those 
corresponding to commercial standards.
Animals
 Twenty-four female Sprague-Dawley rats (180-
200 g each), 126 female Swiss mice (20-25 g each) and 
twenty female and twenty male CF1 mice were used. 
Animals were housed under standard environmental 
conditions (22±1 °C and a 12 h light/dark cycle), with free 
access to a standard commercial diet and water ad libitum. 
Efforts were made to minimize animal suffering. Animals 
were handled following international guidelines and local 
regulations concerning the care and use of laboratory 
animals for biomedical research (Institute of Laboratory 
Animal Resources, 1996). Experiments with animals 
were approved by The Ethical Committee for the Care 
and Use of Laboratory Animals of Facultad de Farmacia 
y Bioquímica, Universidad de Buenos Aires (Ethics 
approval: EXP-FYB 0745846/2012).  
Drugs 
 Atropine, indomethacin, lambda carrageenan, 
morphine sulfate and naloxone were purchased from 
Sigma Chemical Co (St. Louis, Mo., USA). Acetic acid 
was purchased from Merck (Darmstadt, Germany). 
Antinociceptive activity
Acetic acid-induced abdominal writhing
 The test was performed as described by Collier et 
al. (1968). Nociception was induced by an intraperitoneal 
(i.p.) injection of 1.0% acetic acid, (0.1 mL/10 g body 
weight). Groups of eight swiss mice were treated with the 
decoction of the C. diffusum either 30 min (10, 30, 100 
and 300 mg/kg, i.p.) or 60 min (100, 300 and 1000 mg/
kg, p.o.) before the administration of acetic acid. A group 
of eight mice was treated with indomethacin (10 mg/kg 
i.p.) as reference drug. Control animals received the same 
volume of saline solution (10 mL/kg). Animals were 
observed in experimental cages. In order to assess the 
participation of different systems on the antinociceptive 
effect of C. diffusum, a separate group of mice was 
pretreated either with atropine (2 mg/kg i.p.) or naloxone 
(5 mg/kg i.p.) 30 min, before  the administration of the 
aqueous extract (30 mg/kg i.p.). Hand-operated counters 
and stopwatches were employed to score the number of 
abdominal writhes (full extension of both hind paws). The 
writhes were cumulatively counted over a period of 20 min 
immediately after the injection of acetic acid. The doses 
of extract employed had been previously determined by 
in our laboratory. A significant reduction in the number 
of abdominal contractions between control and pretreated 
animals was considered indicative of antinociceptive 
activity. 
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Hot-plate test
 The hot-plate test was used to measure response 
latencies according to the method described by Eddy & 
Leimbach (1953), with minor modifications. Briefly, Swiss 
mice were placed on an Ugo Basile hot-plate maintained 
at 56 ºC and the time between placement of the mouse on 
the platform and shaking or licking any paws or jumping 
was recorded as the hot-plate latency. Mice with baseline 
latencies higher than 10 s were eliminated from the study. 
Twenty-four hours before, the baseline latencies were 
determined. At the moment of the test, groups of five 
animals were treated with the decoction of C. diffusum 
(125, 250 and 500 mg/kg i.p.), morphine (10 mg/kg, i.p.) 
or saline solution (10 mL/kg, i.p.) and left for 30 min. After 
this period the latencies were determined at 30, 60 and 90 
min after each administration. A separate group of mice 
was pretreated with naloxone (5 mg/kg, i.p.) 30 min before 
the administration of the aqueous extract (500 mg/kg i.p.). 
A significant increase of the latency was considered as 
indicative of antinociceptive activity.
Anti-inflammatory activity
Carrageenan-induced oedema in rats
 Paw swelling was induced by sub-plantar 
injection of 0.1 mL of 1% sterile lambda carrageenan 
in saline solution into the right hind paw (Winter et al., 
1962). Groups of six Sprague-Dawley rats were used in 
each treatment. 
 The decoction of C. diffusum was administered at 
doses of 30 and 100 mg/kg (i.p.) 30 min before the injection 
of carrageenan. Indomethacin (10 mg/kg i.p.) was used 
as reference anti-inflammatory drug. The control group 
received vehicle only (1 mL/kg i.p.). The inflammation was 
quantified by measuring the volume displaced by the paw, 
using a plethysmometer (Ugo Basile) at different times 
after the injection of carrageenan. The difference between 
the left and the right paw volumes was determined; the 
degree of inflammation was obtained by the difference 
between each time (1, 3, 4 and 5 h) and basal time (0 h). 
Acute toxicity
 Groups of ten CF-1 mice (six weeks old), five 
male and five female, were used. The control group 
received only vehicle (water) and the other group received 
3 g/kg (0.5 mL/25 g body weight) of the aqueous extract 
of C. diffusum p.o., by means of a gastric catheter. Animals 
were observed twice a day, for up to fifteen consecutive 
days. Apart from the number of deaths, other parameters 
such as weight loss, abdominal constrictions, palpebral 
ptosis, movement, lethargy, stereotypy, ataxia, tremors, 
convulsions, diarrhoea and presence of secretions were 
taken into account. Dead animals were subjected to 
necropsy. Liver, lungs, heart, kidneys and stomach were 
evaluated in order to detect macroscopic changes. 
Statistical analysis
 Data were presented as the mean±SEM. The 
statistical significance of differences between groups 
was assessed by  analysis of variance (ANOVA) 
followed by Dunnett’s test for hot plate and acetic acid-
induced abdominal writhing tests or Bonferroni test for 
carrageenan-induced oedema in rats. p values less than 0.05 
were considered as indicative of significance. Statistical 
analysis was carried out using statistical package (Graph 
Pad software, Inc., USA).
Results
Phytochemical analysis
 The HPLC analysis of the decoction of C. 
diffusum showed the presence of chlorogenic acid (Rt: 
4.57 min), caffeic acid (Rt: 5.54 min), quercetin-3-O-β-D-
galactoside (hyperoside; Rt: 10.43 min), quercetin-3-O-β-
D-glucoside (isoquercitrin; Rt: 15.11 min), quercetin-3-O-
β-D-rhamnoside (quercitrin; Rt: 16.53 min), kaempferol-3-
O-α-L-rhamnoside (afzelin; Rt: 19.43 min), quercetin (Rt: 
30.57 min), apigenin (Rt: 37.01 min), and kaempferol (Rt: 
40.37 min). That metabolites were identified in comparison 
with external standards (Figure 1). 
 
Figure 1. HPLC chromatogram of Chiliotrichum diffusum 
extract. Peaks indicate the following: 1. chlorogenic acid; 2. 
caffeic acid; 3. quercetin-3-O-β-D-galactoside (hyperoside); 4. 
quercetin-3-O-β-D-glucoside (isoquercitrin); 5. quercetin-3-O-
β-D-rhamnoside (quercitrin); 6. kaempferol-3-O-α-L-rhamnoside 
(afzelin); 7. Quercetin; 8. Apigenin; 9. Kaempferol.
Antinociceptive  activity
Acetic acid-induced writhing
 The antinociceptive activity of C. diffusum was 
evaluated in the writhing test. The pretreatment of mice with 
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the decoction (10-300 mg/kg i.p. 30 min before stimulus) 
produced a dose-related inhibition of acetic acid-induced 
writhing response (ED50 35 mg/kg; 95% confidence 
limits: 21-51 mg/kg). Moreover, the oral administration of 
the extract induced a significant inhibition of the writhing 
response (ED50 709 mg/kg; 95 % confidence limits: 
558-921 mg/kg). Indomethacin (10 mg/kg i.p.) induced 
an inhibition of 75.7%. The mechanism of action of C. 
diffusum was investigated by pre-treating  animals with 
drugs that interfere in opiod and cholinergic systems. 
The pre-treatment with atropine (2 mg/kg i.p.) did not 
modify the antinociceptive response elicited by the extract 
whereas naloxone (5 mg/kg) significantly prevented the 
antinociception caused by C. diffusum (Table 1).
Table 1. Effect of decoction of Chiliotrichum diffusum in the 
acetic acid-induced abdominal writhing test.
Treatment Nº writhings Inhibition (%)
Control 33±3 ----
C. diffusum 10 mg/kg i.p. 31±5 6.0
C. diffusum 30 mg/kg  i.p. 12±3** 63.6
C. diffusum 100 mg/kg i.p. 7±3** 78.8
C. diffusum 300 mg/kg i.p. 4±2** 87.9
C. diffusum 30 mg/kg 
i.p.+atropine
15±4** 54.5
C. diffusum 30 mg/kg 
i.p.+naloxone
25±5# 24.2
indomethacin 10 mg/kg i.p. 8±3** 75.7
Control 32±4
C. diffusum 100 mg/kg p.o. 34±4 0.0
C. diffusum 300 mg/kg p.o. 21±3* 34.4
C. diffusum 1000 mg/kg p.o. 14±3** 56.2
Results were obtained by intraperitoneal (i.p.) and oral (p.o.) 
administration of decoction of C. diffusum. Each value represents the 
mean±S.E.M. of results from eight mice. Statistical differences were 
determined by ANOVA followed Dunnett’s test. *p<0.05, **p<0.01 
(compared with the corresponding control values injected with vehicle 
alone); #p<0.05 (compared with C. diffusum 30 mg/kg i.p. group).
Hot-plate test
 The animals treated with morphine (10 mg/kg, 
i.p.) showed a marked increase in latency at all times post-
administration whereas the decoction exerted a significant 
increase in the latency only at 60 and 90 min when the 
dose of 500 mg/kg i.p. was used.
 The antinociceptive activity of the extract 
employed at 500 mg/kg i.p. was also significantly 
suppressed by pretreatment with naloxone (5 mg/kg) 
(Table 2), confirming the participation of the opiod system 
in the antinociceptive activity of C. diffusum.
Table 2. Effect of decoction of Chiliotrichum diffusum in the hot 
plate test.
Treatment
Latency time (s)
30 min 60 min 90 min
control 13.5±1.5 10.0±1.2 8.6±1.0
C. diffusum 125 mg/kg i.p. 14.6±2.6 10.5±3.0 9.7±1.5
C. diffusum 250 mg/kg i.p. 15.5±0.9 13.2±2.8 12.9±3.2
C. diffusum 500 mg/kg i.p. 19.8±1.8 26.5±3.1* 25.9±2.9*
C. diffusum 500 mg/kg 
i.p.+naloxone 5 mg/kg i.p. 14.6±2.6 8.7±2.0
# 4.5±1.1#
morphine 10 mg/kg i.p. 25.2±1.2* 28.3±2.1* 29.0±1.9*
Results were obtained by intraperitoneal (i.p.) administration of decoction 
of C. diffusum. Each value represents the mean±S.E.M. of results from 
five mice. Statistical differences were determined by ANOVA followed 
Dunnett’s test. *p<0.01 (compared with the corresponding control group 
injected with vehicle alone); #p<0.01 (compared with C. diffusum 500 
mg/kg i.p. group).
Anti-inflammatory activity
Carrageenan-induced oedema test.
 The local injection of carrageenan induced a 
gradual increase in the hind paw oedema volume in the 
control group. The effect was evident from the first hour 
after the injection of the phlogistic agent and persisted up 
to 5 h later with a peak oedema volume being observed 
after 3 h of the injection. The treatment with indomethacin 
(the positive control) induced a significant inhibitory effect 
on paw swelling. The aqueous extract induced a significant 
anti-inflammatory activity at dose of 100 mg/kg, while the 
dose of 30 mg/kg did not induce any effect in this model 
(Figure 2).
 
Figure 2. Anti-inflammatory activity of Chiliotrichum diffusum 
in carrageenan induced hind paw oedema. Results were obtained 
by intraperitoneal administration of decoction of Chiliotrichum 
diffusum, indomethacin and vehicle (control group). Each value 
represents the mean±SEM of results from six rats. Statistical 
differences from the control group were determined by ANOVA 
followed by Bonferroni test. *p<0.05; **p<0.01.
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Acute toxicity
 The oral LD50 of the decoction was greater than 3 
g/kg. After the administration of the extract, no significant 
difference in body weight was observed between the 
control and treated group (data not shown). Besides, the 
extract did not produce any sign of toxicity at the tested 
dose during the period of observation and at necropsy, no 
macroscopic changes in organs were detected in the treated 
groups. These results suggested that the extracts have a 
low toxicity.
Discussion
 The main finding of the present study is that 
the extract possesses significant antinociceptive activity 
on models of acute pain induced by a noxious chemical 
such as acetic acid, as well as by a thermal stimulus. The 
extract also proved to have anti-inflammatory activity 
on carrageenan-induced rat paw oedema. The work 
presented herein represents the first attempt to provide 
pharmacological evidence of antinociceptive and anti-
inflammatory effects of this plant. 
 The systemic administration of Chiliotrichum 
diffusum (G. Forst.) Kuntze, Asteraceae, reduced pain-
related behaviour caused by the administration of acetic 
acid in the writhing test. The latter is a classical model 
widely accepted to screen new agents with antinociceptive 
activity where both neurogenic and/or inflammatory pain 
are involved. Pain transmission is a complex mechanism 
that involves interaction of peripheral and central 
structures and different modulatory pathways (Ossipov et 
al., 2010). In order to elucidate the mechanisms by which 
C. diffusum exerts its antinociceptive effect in a chemical 
model of nociception in mice, both cholinergic and opiod 
systems were evaluated. Although the activity of M1 
receptors have been found to increase the pain threshold 
in a visceral pain model (Ikeda et al., 2001; Wang et al., 
2005), the blockade of muscarinic receptors with atropine 
failed to inhibit the antinociception induced by the extract, 
indicating that the cholinergic system was not involved 
in the effect induced by C. diffusum. However, the opiod 
system seemed to be involved, at least in part, in the 
antinociceptive activity of the extract. Since the algesic 
effects of acetic acid are due to the release of high levels 
of mediators such as histamine, serotonin, bradykinin, 
cytokines and eicosanoids in peritoneal fluid, and knowing 
that these mediators reduce the threshold of nociception 
and stimulate nociceptive fibers, it could be hypothesized 
that the effect of the extract might also be accomplished by 
a peripheral reduction in the synthesis, of prostaglandins. 
In order to evaluate different types of pain the hot plate 
test was used. This is a useful method for the evaluation 
of central antinociceptive activity, as well as a validated 
model for opioid-derived antinociceptive compounds. 
The decoction of C. diffusum decreased thermal-induced 
pain and this effect was reversed by the pretreatment with 
naloxone, reinforcing the notion that the antinociceptive 
activity of the aqueous extract of C. diffusum is related to 
the activation of the opioid system.
 Since the route of administration is one of the most 
important factors affecting the results of in vivo methods, 
the i.p. administration was chosen for primary screening. 
It is noteworthy that in this study the bioavailability of 
the extract was quite different in accordance with the 
route of administration used. Since C. diffusum showed 
the highest antinociceptive activity when administered 
by the intraperitoneal route, it could be speculated that an 
extensive hepatic first pass metabolism might be the main 
reason for the low bioavailability achieved by the oral 
route. 
 Further experiments were conducted to investigate 
a potential systemic anti-inflammatory activity of the 
extract. The carrageenan-induced paw edema in rats is 
representative of the inflammatory phenomena occurring 
during the early stages of an acute process and it is widely 
accepted as a useful phlogistic tool and highly sensitive test 
to assess novel anti-inflammatory drugs. The carrageenan 
injection produces a biphasic event. In the first phase, 
during the first hour, histamine, serotonin, and bradykinin 
are the mediators involved, while prostaglandins are 
implied in the second phase (3-5 h). Results demonstrated 
that the administration of 100 mg/kg of the decoction of 
C. diffusum induced a significant inhibition of paw edema 
starting 3 h after carrageenan administration. The latter 
effect was similar to that obtained with indomethacin, 
a known nonselective cyclooxygenase (COX) enzyme 
inhibitor.
 In view of the results obtained in the 
pharmacological assays and taking into account the lack 
of literature data concerning toxicity, the safety of the 
decoction was evaluated. The i.p. LD50 was greater than 
3 g/kg in mice, suggesting that the extracts have a low 
toxicity. 
 According to the phytochemical analysis, the 
presence of different flavonoids such as flavones (apigenin) 
and flavonols (quercetin, hyperoside, isoquercitrin, 
quercitrin, kaempferol and afzelin) were identified. 
Moreover, other sorts of polyphenolic compounds, 
phenolic acids (chlorogenic and caffeic acids) were found. 
Some of these compounds have been isolated from other 
members of the Asteraceae family growing in Argentina, 
e.g. hyperoside, chlorogenic and caffeic acids from 
Eupatorium arnottianum (Clavin et al., 2007).
 Among different groups of natural products, 
the flavonoids are a group of chemical entities widely 
distributed in the Plantae Kingdom and a great number of 
pharmacological effects have been ascribed to them (Di 
Carlo et al., 1999). 
 Anti-inflammatory and antinociceptive activities 
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of most of the compounds identified in the decoction 
have been reported so far. Quercetin and three quercetin 
derivates (hyperoside, isoquercitrin and quercitrin) 
(Morikawa et al., 2003; Erdemoglu et al., 2008; Valério 
et al., 2009), chlorogenic and caffeic acids, natural 
compounds widely distributed in plants, have previously 
shown to possess such activities (Morikawa et al., 2003; 
Dos Santos et al., 2006; Clavin et al., 2007; Erdemoglu 
et al., 2008; Valério et al., 2009; De Campos Buzzi et al., 
2009). During the inflammation process, caffeic acid has 
shown to be an inhibitor lipoxygenase (Gugliucci et al., 
2009), quercitrin and kaempferol-3-O-glucoside have 
proven to be inhibitors of COX-1 and COX-2 (Vanisree et 
al., 2008). Likewise, apigenin and kaempferol derivatives 
have exhibited in vitro and in vivo activities related to the 
inflammatory response (Smolinski & Pestka, 2003; De 
Melo et al., 2009). 
 Taking into account data presented herein, the 
presence of compounds identified in the aqueous extract 
could justify, at least in part, the observed effect.
 Although in this work the usefulness of this 
decoction has not been studied in ocular ailments, it is 
known that some polyphenols-rich medicinal plants, have 
been used with this purpose since ancient times (Abdul 
et al., 2010) and they have also shown anti-inflammatory 
systemic activity. Therefore, it is likely that this extract 
might display a beneficial activity on ocular diseases. 
However, this effect must be subjected to evaluation 
employing suitable animal models. 
 The results presented herein demonstrated, for 
the first time, that the decoction of C. diffusum possessed 
antinociceptive and anti-inflammatory effects that may be 
related to the presence of flavones, flavonols and phenolic 
acids. The opiod system seems to be involved in the 
mechanism of antinociception of the aqueous extract. 
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